These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10733609

  • 1. Validation of protein-based alignment in 3D quantitative structure-activity relationships with CoMFA models.
    Golbraikh A, Bernard P, Chrétien JR.
    Eur J Med Chem; 2000 Jan; 35(1):123-36. PubMed ID: 10733609
    [Abstract] [Full Text] [Related]

  • 2. 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors.
    Nazari M, Tabatabai SA, Rezaee E.
    Curr Comput Aided Drug Des; 2018 Jan; 14(4):391-397. PubMed ID: 30047333
    [Abstract] [Full Text] [Related]

  • 3. Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment.
    Bernard P, Kireev DB, Chrétien JR, Fortier PL, Coppet L.
    J Comput Aided Mol Des; 1999 Jul; 13(4):355-71. PubMed ID: 10425601
    [Abstract] [Full Text] [Related]

  • 4. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors.
    Tong W, Collantes ER, Chen Y, Welsh WJ.
    J Med Chem; 1996 Jan 19; 39(2):380-7. PubMed ID: 8558505
    [Abstract] [Full Text] [Related]

  • 5. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
    Chaudhaery SS, Roy KK, Saxena AK.
    J Chem Inf Model; 2009 Jun 19; 49(6):1590-601. PubMed ID: 19441865
    [Abstract] [Full Text] [Related]

  • 6. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N, Lecanu L, Greeson J, Papadopoulos V.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6277-80. PubMed ID: 17049234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors.
    Sippl W, Contreras JM, Parrot I, Rival YM, Wermuth CG.
    J Comput Aided Mol Des; 2001 May 15; 15(5):395-410. PubMed ID: 11394735
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.
    Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M, Cavrini V.
    J Med Chem; 2000 May 18; 43(10):2007-18. PubMed ID: 10821713
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S, Barron MG.
    Toxicol Sci; 2015 Nov 18; 148(1):60-70. PubMed ID: 26202430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.